Lynx1 Capital Management LP

Korro Bio, Inc. · 10% Owner

Lynx1 Capital Management LP is listed in filings as 10% Owner at Korro Bio, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including purchase activity. Recent filings connect the profile to Korro Bio, Inc. (KRRO), TScan Therapeutics, Inc. (TCRX), Cullinan Therapeutics, Inc. (CGEM), and Passage Bio, Inc. (PASG). The current snapshot covers public activity from Nov 19, 2024 to Apr 2, 2026. Reported amounts are shown as $5.5K to $68.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
TScan Therapeutics, Inc.TCRX$5.6k6.2k sharesBuyDec 23, 2025$0.8989$0.9099
TScan Therapeutics, Inc.TCRX$68k75.5k sharesBuyDec 22, 2025$0.90$0.9099
TScan Therapeutics, Inc.TCRX$72k80.1k sharesBuyDec 19, 2025$0.8989$0.9099
Cullinan Therapeutics, Inc.CGEM$1M165.7k sharesBuyOct 28, 2025$8.40$16.41
Cullinan Therapeutics, Inc.CGEM$253k32.2k sharesBuyOct 17, 2025$7.84$16.41
Cullinan Therapeutics, Inc.CGEM$1M150k sharesBuyOct 16, 2025$8.86$16.41
Cullinan Therapeutics, Inc.CGEM$409k51.5k sharesBuyOct 15, 2025$7.94$16.41
Cullinan Therapeutics, Inc.CGEM$114k15k sharesBuyOct 14, 2025$7.59$16.41
Cullinan Therapeutics, Inc.CGEM$2M277.3k sharesBuyOct 10, 2025$7.36$16.41
Cullinan Therapeutics, Inc.CGEM$4M626k sharesBuyOct 9, 2025$6.70$16.41
Cullinan Therapeutics, Inc.CGEM$4M556.3k sharesBuyOct 8, 2025$6.46$16.41
Passage Bio, Inc.PASG$83k11.9k sharesBuySep 15, 2025$6.99$4.83
Passage Bio, Inc.PASG$138k19.8k sharesBuySep 12, 2025$6.99$4.83
Passage Bio, Inc.PASG$2.3k325 sharesBuySep 11, 2025$6.96$4.83
Passage Bio, Inc.PASG$379k66.4k sharesBuyJul 24, 2025$5.71$4.83
Passage Bio, Inc.PASG$283k49.3k sharesBuyJul 23, 2025$5.74$4.83
Passage Bio, Inc.PASG$71k13.1k sharesBuyJul 22, 2025$5.44$4.83
TScan Therapeutics, Inc.TCRX$1M1.2M sharesBuyMay 20, 2025$1.20$0.9099
TScan Therapeutics, Inc.TCRX$2M1.4M sharesBuyMay 19, 2025$1.20$0.9099
Passage Bio, Inc.PASG$241k373.6k sharesBuyDec 27, 2024$0.6451$4.83
TScan Therapeutics, Inc.TCRX$7507.5M sharesBuyDec 26, 2024$0.0001$0.9099
TScan Therapeutics, Inc.TCRX$290k100k sharesBuyDec 13, 2024$2.90$0.9099
TScan Therapeutics, Inc.TCRX$96k31.8k sharesBuyDec 12, 2024$3.01$0.9099
Passage Bio, Inc.PASG$20k29.3k sharesBuyNov 27, 2024$0.6711$4.83
Passage Bio, Inc.PASG$118k167.1k sharesBuyNov 26, 2024$0.7075$4.83
Passage Bio, Inc.PASG$147k260k sharesBuyNov 25, 2024$0.5641$4.83
TScan Therapeutics, Inc.TCRX$4.1k947 sharesBuyNov 15, 2024$4.34$0.9099